Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-12-11-Speech-2-285"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20011211.12.2-285"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Madam President, first of all, I would like to thank the rapporteur for his work. At a time when there are many questions with regard to what Europe is doing and what it is about, the one area where we can claim to have success and where we have responded to the concerns of European citizens is in the area of public health. We have been to the fore with in bringing forward innovative programmes tackling common diseases such as cancer, biological hazards, risks to food and food safety, and also the ongoing problems of BSE and foot-and-mouth disease.
The one certainty, the one foundation stone that European citizens could depend on was the European Union. This has been particularly the case because of the role of our present Commissioner, David Byrne with his proactive attitude to dealing with problems head on, refusing to hide behind any of the cloaks or daggers generally used to get through any difficult political situation. Instead, he delivers clear and factual information quickly to the people. What we are asking for in Parliament here, in the second reading of the Trakatellis, report is a continuation of that relationship with the European citizen, a continuation of the confidence that the European citizens have in us to deliver for them in real terms.
I, like my colleagues, do not think that the European Union should be involved in setting out treatment programmes or setting out the delivery of medical services to individual citizens – that is obviously best dealt with at national or local level.
However, there is much that we can learn from each other. There are practices with regard to medical devices and new technologies which are in use in one Member State and are not even discussed in another. The Commission and Europe can act as the honest broker in bringing together these sides to ensure that we deliver the best possible remedies for people within the European Union.
I have one area of concern in particular – and there is nothing in the report to help resolve the problem – and that is having a clear account of the illness and diseases suffered right across the European Union. For instance, in areas such as autism, polio, cancer – breaking down the individual cancers is probably easier to collate than anything else – cystic fibrosis and other generic and genetic diseases, we have seen continuing problems for people trying to give services to sufferers. If the Commissioner could come forward with an idea of being the collator of information, at least we could then say that there is 10% or 12% or 50%, instead of using guess-work or guess-figures as regards the extent of disease, illness or disability prevalent in our Union. Along with my colleagues, I will support the measures looking for increased funding to be made available. We must live in the real world. The work we are asking for costs money, whether in terms of personnel or resources, and we should be fully supportive of that."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples